Furthermore, despite not meeting the threshold for statistical power defined by this study, there is an observable trend that only malignant Bethesda III nodules demonstrated BRAF V600E (n = 4) (p = 0.053) mutations on molecular testing, three of which led to aggressive cancer (Table 4). The gene discussed is BRAF; the disease is cancer.